These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98. International Commission on Radiological Protection Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284 [TBL] [Abstract][Full Text] [Related]
27. Dosimetric study of CO-60 source step size in uterine cervix intracavitary HDR brachytherapy. Shukla AK; Rana BS; Singh NP; Kumar S Brachytherapy; 2019; 18(2):180-185. PubMed ID: 30616914 [TBL] [Abstract][Full Text] [Related]
28. Lessons learned from investigations of therapy misadministration events. Ostrom LT; Rathbun P; Cumberlin R; Horton J; Gastorf R; Leahy TJ Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):227-34. PubMed ID: 12118556 [TBL] [Abstract][Full Text] [Related]
29. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446 [TBL] [Abstract][Full Text] [Related]
30. [Prostate cancer brachytherapy]. Pommier P; Guérif S; Peiffert D; Créhange G; Hannoun-Lévi JM; de Crevoisier R Cancer Radiother; 2016 Sep; 20 Suppl():S210-5. PubMed ID: 27523412 [TBL] [Abstract][Full Text] [Related]
31. Estimation of doses to personnel and patients during endovascular brachytherapy applications. Kirisits C; Hefner A; Wexberg P; Pokrajac B; Glogar D; Pötter R; Georg D Radiat Prot Dosimetry; 2004; 108(3):237-45. PubMed ID: 15031445 [TBL] [Abstract][Full Text] [Related]
32. Le Fort I osteotomy and low-dose rate Ir192 brachytherapy for treatment of recurrent nasopharyngeal tumours. Hall CE; Harris R; A'Hern R; Archer DJ; Rhys-Evans P; Henk JM; Harrington KJ; Nutting CM Radiother Oncol; 2003 Jan; 66(1):41-8. PubMed ID: 12559519 [TBL] [Abstract][Full Text] [Related]
33. Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and 9011 125I brachytherapy sources. Rivard MJ Med Phys; 2009 Feb; 36(2):486-91. PubMed ID: 19291987 [TBL] [Abstract][Full Text] [Related]
34. Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications. Steggerda MJ; van der Poel HG; Moonen LM Brachytherapy; 2010; 9(4):319-27. PubMed ID: 20691644 [TBL] [Abstract][Full Text] [Related]
36. The dosimetry of brachytherapy-induced erectile dysfunction. Merrick GS; Butler WM Med Dosim; 2003; 28(4):271-4. PubMed ID: 14684193 [TBL] [Abstract][Full Text] [Related]
37. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy. Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K Tumori; 2014; 100(3):265-71. PubMed ID: 25076236 [TBL] [Abstract][Full Text] [Related]
38. [Exposure dose reduction to medical staff during intracoronary radiotherapy with phosphorus-32]. Fukuda A Nihon Hoshasen Gijutsu Gakkai Zasshi; 2003 Aug; 59(8):921-6. PubMed ID: 12960943 [No Abstract] [Full Text] [Related]
39. [Remarks on the dosage problem in HDR brachytherapy]. Kneschaurek P Strahlenther Onkol; 1998 Sep; 174(9):468-72. PubMed ID: 9765688 [TBL] [Abstract][Full Text] [Related]
40. Emergency localization of radioactive seeds lost during intracoronary brachytherapy. Krüll A; Köster R; Bohuslavizki KH; Todorovic M; Schmidt R; Thurmann H; Brockhoff C; Schwarz R; Münzel T; Alberti W Catheter Cardiovasc Interv; 2004 Aug; 62(4):482-4. PubMed ID: 15274158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]